Fig. 3From: Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS)Serum LCN2 levels in human patients. a Detection of serum LCN2 levels in patients with AS-IBD (coexisting AS and IBD; nā=ā57), AS (ankylosing spondylitis; nā=ā462), IBD (inflammatory bowel disease; nā=ā85), HC (healthy control; nā=ā158), and MBP (mechanical back pain; nā=ā52). b Detection of serum LCN2 levels of different degrees of ankylosis (mSASSS >ā10 vs. MSASSS ā¤ā10), in AS patients with or without IBD. One-way analysis of variance (ANOVA) followed by Bonferroniās multiple comparison test was usedBack to article page